UFT and its metabolites inhibit cancer-induced angiogenesis: Via a VEGF-related pathway

ONCOLOGY

Volumn 14, Issue 10 SUPPL. 9, 2000, Pages 68-71

  Basaki, Yuji ^a   Aoyagi, Kumio ^a   Chikahisa, Lumi ^a   Miyadera, Kazutaka ^a   Hashimoto, Akihiro ^a   Yonekura, Kazuhiko ^a   Okabe, Soko ^a   Shibata, Jiro ^a   Wierzba, Konstanty ^a   Yamada, Yuji ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 UFT PROTOCOL; 1-UFT PROTOCOL; ANTINEOPLASTIC AGENT; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; TEGAFUR; URACIL; VASCULOTROPIN; VASCULOTROPIN A;

AIR SAC; ANIMAL; ARTICLE; BIOASSAY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM; KIDNEY CARCINOMA; KIDNEY TUMOR; LUNG TUMOR; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; UMBILICAL VEIN;

AIR SACS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL ASSAY; CARCINOMA, RENAL CELL; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPHOKINES; MICE; NEOVASCULARIZATION, PATHOLOGIC; TEGAFUR; UMBILICAL VEINS; URACIL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034304763     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pazdur R: Beyond 5-fluorouracil. Oncology 13(suppl):15-16, 1999.
2. Taguchi H, Takaoka K, Matsuda M: A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT. Gan To Kagaku Ryoho 19:2395-2398, 1992.
3. Fukuoka H, Takeda M, Nomura S, et al: Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: A case report. Hinyokika Kiyo 37:541-544, 1991.
4. Pazdur R, Lassere Y, Rhodes V, et al: Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300, 1994.
5. Kurebayashi J, Sonoo H: Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice. Gan To Kagaku Ryoho 22:665-670, 1995.
6. Matsushita K, Kuramitsu Y, Ohiro Y, et al: Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs 9:343-50, 1998.
7. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65, 1977.
8. Weinstat-Saslow D, Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8:401-407, 1994.
9. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31, 1995.
10. Kumar R, Yoneda J, Bucana CD, et al: Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 12:749-757, 1998.
11. Cronauer MV, Hittmair A, Eder IE, et al: Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate 31:223-233, 1997.
12. Shibusa T, Shijubo N, Abe S: Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res 4:1483-1487, 1998.
13. Yonekura K, Basaki Y, Chikahisa L, et al: UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin Cancer Res 5:2185-2191, 1999.
14. Wu AT, Au JL, Sadee W: Hydroxylated metabolites of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil in rats and rabbits. Cancer Res 38:210-214, 1978.
15. Au JL, Sadee W: Activation of Ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone. Cancer Res 40: 2814-2819, 1980.